Main

The site is operated with the financial support of the Ministry of Digital Development, Communications and Mass Media of the Russian Federation.

The information resource uses recommendation technologies. More detailed

Registered by the Federal Service for Supervision of Communications, Information Technology and Mass Communications. Certificates of registration Certificate of registration: EL № FS 77 - 76208 dated July 8, 2019, Certificate of registration: EL № FS 77 - 72003 dated December 26, 2017.

Фийон отрицает организацию встречи ливанского бизнесмена с Путиным

20 Марта
All results

Live broadcast

Science and technology

NIC Gamalei named the time frame for the creation of an individual cancer vaccine

NITZ Gamalei: it takes about three months to create a cancer vaccine

Sun, 04/05/2026 - 06:44

Photo: IZVESTIA/Sergey Lantyukhov

Озвучить текст

Select important

Off

It takes about three months to create an individual cancer vaccine for the treatment of melanoma. This was announced on April 5 by Vladimir Gushchin, Deputy Director for Scientific Work at the Gamaleya Research Center for Epidemiology and Microbiology.

"Now we need about three months to create the drug. Over time, this period will be shortened," Guschin said in an interview with TASS.

It is noted that this period will be shortened later.

The news is being updated

Переведено сервисом «Яндекс Переводчик»

To share:

Live broadcast

Subscribe and get the news first

Copyright for the iz.ru portal content visualisation system, as well as for the source data, including texts, photos, audio and video materials, graphic images, other works and trademarks, belongs to "MIC Izvestia" LLC

Partial quotation is possible only with a hyperlink to en.iz.ru

The site is operated with the financial support of the Ministry of Digital Development, Communications and Mass Media of the Russian Federation.

The advertiser is responsible for the content of any advertising materials posted on the portal.

The information resource uses recommendation technologies. More detailed

The news, analytics, forecasts and other materials presented on this website do not constitute an offer or recommendation to buy or sell any assets.

Registered by the Federal Service for Supervision of Communications, Information Technology and Mass Communications. Certificates of registration Certificate of registration: EL № FS 77 - 76208 dated July 8, 2019. , Certificate of registration: EL № FS 77 - 72003 dated December 26, 2017.